| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.5M | -65.5% |
| R&D Expense | $0 | — |
| SG&A Expense | $13.5M | +16.1% |
| Operating Income | -$44.9M | -43.3% |
| Income Tax | $0 | — |
| Net Income | -$44.2M | -41.0% |
| EPS (Basic) | -$0.84 | -31.2% |
| EPS (Diluted) | -$0.84 | -31.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $37.1M | -59.1% |
| Short-term Investments | $26.6M | — |
| Current Assets | $67.3M | -27.5% |
| Total Assets | $68.7M | -26.6% |
| Current Liabilities | $7.7M | +40.6% |
| Stockholders' Equity | $61.0M | -30.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$36.7M | -38.0% |
| Investing Cash Flow | -$26.5M | — |
| Financing Cash Flow | $9.6M | +1452.5% |